Health Effects of Inhaled Engineered Nanoscale Materials

Nanoscience and Nanotechnology: Environmental and Health Impacts

Volumn , Issue , 2008, Pages 367-404

  Madl, Amy K ^a,b   Pinkerton, Kent E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CARDNO CHEMRISK   (United States)

Author keywords

Experimental studies and human exposures bridging knowledge gap; Inhaled engineered nanoscale materials health effects; Single walled carbon nanotubes (SWCNTs) and multi walled carbon nanotubes(MWCNTs)

Indexed keywords

EID: 70350465729     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470396612.ch15     Document Type: Chapter

References (183)

1. Alivisatos, P. Colloidal quantum dots. From scaling laws to biological applications. Pure Appl Chem 2002;72(1-2):3-9.
2. Drexler, K.E. Nanosystems: Molecular, Machinery, Manufacturing, and Composition. New York, NY: Wiley-Interscience Publication; 1992.
3. Hu, J.T., Odom, T.W., Lieber, C.M. Chemistry and Physics in one dimension: synthesis and properties of nanowires and nanotubes. Accounts Chem Res 1999;32(5):435-445.
4. Lieber, C. Nanoscale science and technology: building a big future from small things. MRS Bull 2003;28(77):486-491.
5. Navrotsky, A. Thermochemistry of nanomaterials. Nanoparticles Environ 2001;44:73-103.
6. Smalley, R. Wires of wonder. Technol Rev 2001;104(2):86-91.
7. West, J.L., Halas, N.J. Engineered nanomaterials forbiophotonics applications: improving sensing, imaging, and therapeutics. Ann Rev Biomed Eng 2003;5:285-292.
8. Hawxhurst, D. Project on emerging nanotechnologies: a nanotechnology consumer products inventory. Washington DC: Woodrow Wilson International Center for Scholars. http://www.nanotechproject.org/44.
9. ASTM International Standard terminology relating to nanotechnology, West Consho-hocken, PA: American Society for Testing and Materials (ASTM International); 2006.
10. ICRP. Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection. Ann ICRP 1994;24(1-3): 1-482.
11. Ferin, J. Pulmonary tissue access of ultrafine particles. J Aerosol Med 1991;4(1):57-68.
12. Oberdorster, G., Oberdorster, E., Oberdorster, J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005;113(7): 823-839.
13. Roth, C. Clearance measurements with radioactively labelled ultrafine particles. Ann OccupHyg 1994;38:101-106.
14. Roth, C. Deposition and clearance of fine particles in the human respiratory tract. Ann Occup Hyg 1997;40:503-508.
15. Roth, C. Clearance of the human lungs for ultrafine partcles. J Aerosol Sci 1993;24: S95-S96.
16. Kreyling, W.G., Semmler, M., Moller W. Dosimetry and toxicology of ultrafine particles. J Aerosol Med 2004;17(2):140-152.
17. Semmler-Behnke, M., Takenaka, S., Fertsch, S., Wenk, A., Seitz, J., Mayer, P., Oberdorster, G., Kreyling, W.G. Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect 2007;115(5):728-733.
18. Leong, B.K., Coombs, J.K., Sabaitis, C.P., Rop, D.A., Aaron, C.S. Quantitative morpho-metric analysis of pulmonary deposition of aerosol particles inhaled via intratracheal nebulization, intratracheal instillation or nose-only inhalation in rats. J Appl Toxicol 1998;18(2):149-160.
19. Osier, M., Oberdorster, G. Intratracheal inhalation vs intratracheal instillation: differences in particle effects. Fundam Appl Toxicol 1997;40(2):220-227.
20. Rao, G.V., Tinkle, S., Weissman, D.N., Antonini, J.M., Kashon, M.L., Salmen, R., Battelli, L.A., Willard, P.A., Hoover, M.D., Hubbs, A.F. Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J Toxicol Environ Health A 2003;66(15):1441-1452.
21. Brain, J.D., Knudson, D.E., Sorokin, S.P., Davis MA. Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. Environ Res 1976;11(1): 13-33.
22. Driscoll, K.E., Costa, D., Hatch, G., Henderson, R., Oberdorster, G., Salem, H., Schlesinger, R.B. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity; uses and limitations. Toxicol Sci 2000;55:24-35.
23. Oberdorster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Lunts, A., Kreyling, W., Cox, C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002;65(20):1531-1543.
24. Henderson, R.F., Driscoll, K.E., Harkema, J.R., Lindenschmidt, R.C., Chang, I.Y., Maples, K.R., Barr, E.B. A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats. Fundam Appl Toxicol 1995;24(2): 183-197.
25. Osier, M., Baggs, R.B., Oberdorster, G. Intratracheal instillation versus intratracheal inhalation: influence of cytokines on inflammatory response. Environ Health Perspect 1997;105 (Suppl 5):1265-1271.
26. Finlayson-Pitts, B. Chemistry of the upper and lower atmosphere: theory, experiments, and applications. San Diego, CA: Academic Press; 2000.
27. Oberdorster, G., Utell, M.J. Ultrafine particles in the urban air: to the respiratory tract, and beyond? Environ Health Perspect 2002;110(8):A440-A441.
28. Whitby, K.T., Sverdrup, G.M. California aerosols: their physical and chemical characteristics. Adv Environ Sci Technol 1980;8:477-525.
29. Aitken, R.J., Chaudhry, M.Q., Boxall, A.B., Hull, M. Manufacture and use of nanomaterials: current status in the UK and global trends. Occup Med (Lond) 2006;56(5):300-306.
30. Brouwer, D.H., Gijsbers, J.H., Lurvink, M.W. Personal exposure to ultrafine particles in the workplace: exploring sampling techniques and strategies. Ann Occup Hyg 2004;48 (5):439-453.
31. Ku, B.K., Maynard, A.D. Comparing aerosol surface-area measurements of monodisperse ultrafine silver agglomerates by mobility analysis, transmission electron microscopy and diffusion charging. J Aerosol Sci 2005;36:1108-1124.
32. Ku, B.K., Maynard, A.D. Generation and investigation of airborne silver nanoparticles with specific size and morphology by homogeneous nucleation, coagulation and sintering. J Aerosol Sci 2006;37:452-470.
33. Maynard, A.D., Kuempel, E.D. Airborne nanostructured particles and occupational health. J Nanopart Res 2005;7:587-614.
34. Powers, K.W. Research strategies for safety evaluation of nanomaterials part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 2006;90(2):296-303.
35. Baker, S.E., Cai, W., Lasseter, T.L., Weidkamp, K.P., Hamers, R.J. Covalently bonded adducts of deoxyribonucleic acid (DNA) oligonucleotides with single-wall carbon nanotubes: synthesis and hybridization. Nano Letters 2002;2(12):1413-1417.
36. Dresselhaus, M.S., Dresselhaus, G. Carbon nanotubes: synthesis, structure, properties, and applications. New York, NY: Phaedon Avouris and LINK, Springer; 2001.
37. Williams, K.A., Veenhuizen, P.T.M., de la Torre, B.G., Eritja, R., Dekker, C. Nanotechnology-carbon nanotubes with DNA recognition. Nature 2002;420(6917):761.
38. De Villiers, M.M., Lvov, Y. Nanoshells for drug delivery. In: Kumar, C., editor. Nanomaterials for Medical Diagnosis and Therapy. Weinheim: Wiley-VCH Verlag GmbH & Co.; 2007. pp. 527-556.
39. Han, S.K., Kim, R.S., Lee, J.H., Tae, G., Cho, S.H., Yuk, S.H. Core-shell nanoparticles for drug delivery and molecular imaging. In: Kumar, C., editor. Nanomaterials for Medical Diagnosis and Therapy. Weinheim: Wiley-VCH Verlag GmbH & Co.; 2007. pp. 143-188.
40. Idee, J.M., Port, M., Raynal, I., Schaefer, M., Bonnemain, B., Prigent, P., Robert, P., Robic, C., Corot, C. Superparamagnetic nanoparticles of iron oxides for magnetic resonance imaging applications. In: Kumar, C., editor. Nanomaterials for Medical Diagnosis and Therapy. Weinheim: Wiley-VCH Verlag GmbH & Co.; 2007. pp. 51-84.
41. Rieger, J., Jerome, C., Jerome, R., Auzely-Velty, R. Polymeric nanomaterials-synthesis, functionalization and applications in diagnosis and therapy. In: Kumar, C., editor. Nanomaterials for Medical Diagnosis and Therapy. Weinheim: Wiley-VCH Verlag GmbH & Co.; 2007. pp. 342-408.
42. Yamaguchi, Y., Igarashi, R. NANOEGG technology for drug delivery. In: Kumar, C., editor. Nanomaterials for Medical Diagnosis and Therapy, Weinheim: Wiley-VCH Verlag GmbH & Co.; 2007. pp. 310-341.
43. Cullen, R.T., Tran, C.L., Buchanan, D., Davis, J.M., Searl, A., Jones, A.D., Donaldson, K. Inhalation of poorly soluble particles. I. Differences in inflammatory response and clearance during exposure. Inhal Toxicol 2000;12(12):1089-1111.
44. Renwick, L.C., Donaldson, K., Clouter, A. Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol Appl Pharmacol 2001;172(2):119-127.
45. Tran, C.L., Buchanan, D., Cullen, R.T., Searl, A., Jones, A.D., Donaldson, K. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal Toxicol 2000;12(12):1113-1126.
46. Sayes, C.M., Wahi, R., Kurian, P.A., Liu, Y., West, J.L., Ausman, K.D., Warheit, D.B., Colvin, V.L. Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol Sci 2006;92(1):174-185.
47. 2 particle formulations: impact of surface treatments on particle toxicity. Toxicol Sci 2005;88(2):514-524.
48. 2 particulates substantially encapsulated with pyrogenically deposited, amorphous silica. Part Fibre Toxicol 2006a:3, 3-12.
49. 2 particles: differential responses related to surface properties. Toxicology 2007;230(1):90-104.
50. 2 rods and dots in rats: Toxicity is not dependent upon particle size and surface area. Toxicol Sci 2006a;91(1):227-236.
51. Bermudez, E., Mangum, J.B., Asgharian, B., Wong, B.A., Reverdy, E.E., Janszen, D.B., Hext, P.M., Warheit, D.B., Everitt, J.I. Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. Toxicol Sci 2006;70(1):86-97.
52. Bermudez, E., Mangum, J.B., Wong, B.A., Asgharian, B., Hext, P.M., Warheit, D.B., Everitt, J.I. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 2004;77(2):347-357.
53. Donaldson, K., Li, X.Y., MacNee, W. Ultrafine (nanometre) particle mediated lung injury. J Aerosol Sci 1998;29:553-560.
54. Gilmour, P. Surface free radical activity of PM10 and ultrafine titanium dioxide: a unifying factor in their toxicity? Ann Occup Hyg 1997;41:32-38.
55. Oberdorster, G. Significance of particle parameters in the evaluation of exposure/dose-response relationships of inhaled particles. Inhal Toxicol 1996;8(Suppl):73-89.
56. Oberdorster, G., Ferin, J., Gelein, R., Soderholm, S.C., Finkelstein, J. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ Health Perspect 1992;97:193-199.
57. Oberdorster, G., Gelein, R.M., Ferin, J., Weiss, B. Association of particulate air pollution and acute mortality: involvement of ultrafine particles? Inhal Toxicol 1995;7(1):111-124.
58. NIOSH. Current intelligence bulletin: evaluation of health hazard and recommendations for occupational exposure to titanium dioxide (draft). Atlanta, GA: National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control & Prevention, Department of Human and Health Services; 2005.
59. 2 nanowires made by the "oriented attachment" mechanism. JAm Chem Soc 2004;126(45):14943-14949.
60. Hext, P.M., Tomenson, J.A., Thompson, P. Titanium dioxide: inhalation toxicology and epidemiology. Ann Occup Hyg 2005;49(6):461-472.
61. Hext, P.M. Current perspectives on particulate induced pulmonary tumours. Hum Exp Toxicol 1994;13(10):700-715.
62. ILSI. The relevance of the rat lung response to particle overload for human risk assessment: a workshop consensus report. ILSI Risk Science Institute Workshop Participants. Inhal Toxicol 2000;12(1-2):1-17.
63. Ferin, J. Translocation of particles from the pulmonary alveoli into the interstitium. J Aerosol Med 1992;5(3):179-187.
64. Ferin, J., Oberdorster, G., Penney D.P. Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol 1992;6(5):535-542.
65. Oberdorster, G., Ferin, J., Lehnert B.E. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 1994;102(Suppl 5):173-179.
66. Hu, H., Haddon, R.C., Ni, Y., Montana, V., Parpura, V. Chemically functionalized carbon nanotubes as substrates for neuronal growth. Nano Lett 2004;4:507-511.
67. Lovat, V., Pantarotto, D., Lagostena, L., Cacciari, B., Grandolfo, M., Righi, M., Spalluto, G., Prato, M., Ballerini, L. Carbon nanotube substrates boost neuronal electrical signaling. Nano Lett 2005;5(6):1107-1110.
68. Mattson, M.P., Haddon, R.C., Rao, A.M. Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth. J Mol Neurosci 2000;14(3):175-182.
69. Chen, X., Lee, G.S., Zettl, A., Bertozzi, C.R. Biomimetic engineering of carbon nanotubes by using cell surface mucin mimics. Angew Chem Int Ed Engl 2004; 43 (45):6111-6116.
70. Park, E.J., Brasuel, M., Behrend, C., Philbert, M.A., Kopelman, R. Ratiometric optical PEBBLE nanosensors for real-time magnesium ion concentrations inside viable cells. Anal Chem 2003a;75(15):3784-3791.
71. Park, K.H., Chhowalla, M., Iqbal, Z., Sesti, F. Single-walled carbon nanotubes are a new class of ion channel blockers. J Biol Chem 2003b;278(5a):50212-50216.
72. Bianco, A., Hoebeke, J., Kostarelos, K., Prato, M., Partidos, C.D. Carbon nanotubes: on the road to deliver. Curr Drug Deliv 2005a;2(3):253-259.
73. Bianco, A., Kostarelos, K., Partidos, C.D., Prato, M. Biomedical applications of functionalised carbon nanotubes. Chem Commun (Camb)2005b;5:571-577.
74. Bianco, A., Kostarelos, K., Prato, M. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 2005c;9(6):674-679.
75. Bianco, A., Prato M. Can carbon nanotubes be considered useful tools for biological applications? Adv Mater 2003;15:1765-1768.
76. Gao, B., Bower, C., Lorentzen, J.D., Fleming, L., Kleinhammes, A., Tang, X.P., McNeil, L.E., Wu, Y., Zhou, O. Enhanced saturation lithium composition in ball-milled singlewalled carbon nanotubes. Chem Phys Lett 2000;327(1-2):69-75.
77. Walters, D.A., Casavant, M.J., Qin, X.C., Huffman, C.B., Boul, P.J., Ericson, L.M., Haroz, E.H., O'Connell, M.J., Smith, K., Colbert, D.T., Smalley, R.E. In-plane-aligned membranes of carbon nanotubes. Chem Phys Lett 2001;338(1):14-20.
78. Baughman, R.H. Putting a new spin on carbon nanotubes. Science 2000;290(5495):1310-1311.
79. Lin, Y., Taylor, S., Li, H., ShiralFernando, K.A., Qu, L., Wang, W., Gu, L., Zhou, B., Sun, Y. P. Advances toward bioapplications of carbon nanotubes. J Mater Chem 2004;14:527-541.
80. Kostarelos, K., Lacerda, L., Partidos, C.D., Prato, M., Bianco, A. Carbon nanotubeme-diated delivery of peptides and genes to cells: translating nanobiotechnology to therapeutics. J Drug Deliv Sci Technol 2005;15(1):41-47.
81. Katz, E, Willner, I. Biomolecule-functionalized carbon nanotubes: applications in nano-bioelectronics. Chem Phys Chem 2004;5(8):1084-1104.
82. Fortina, P., Kricka, L.J., Surrey, S., Grodzinski, P. Nanobiotechnology: the promise and reality of new approaches to molecular recognition. Trends Biotechnol 2005;23(4): 168-173.
83. Maynard, A.D., Baron, P.A., Foley, M., Shvedova, A.A., Kisin, E.R., Castranova, V. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J Toxicol Environ Health A 2004;67 (1): 87-107.
84. Huczko, A., Lange, H. Carbon nanotubes: experimental evidence for a null risk of skin irritation and allergy. Fullerene Sci Tech 2001;9(2):247-250.
85. Huczko, A., Lange, H., Calko, E. Fullerenes: experimental evidence for a null risk of skin irritation and allergy. Fullerene Sci Tech 1999;7(5):935-939.
86. Huczko, A., Lange, H., Calko, E., Grubek-Jaworska, H., Droszcz, P. Physiological testing of carbon nanotubes: are they asbestos-like? Fullerene Sci Tech 2001;9(2):251-254.
87. Lam, C.W., James, J.T., McCluskey, R., Hunter, R.L. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 2004;77(1):126-134.
88. Muller, J., Huaux, F., Moreau, N., Misson, P., Heilier, J.F., Delos, M., Arras, M., Fonseca, A., Nagy, J.B., Lison, D. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 2005;207(3):221-231.
89. Shvedova, A.A., Castranova, V., Kisin, E.R., Schwegler-Berry, D., Murray, A.R., Gandelsman, V.Z., Maynard, A., Baron, P. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A 2003;66(20):1909-1926.
90. Shvedova, A.A., Kisin, E.R., Mercer, R., Murray, A.R., Johnson, V.J., Potapovich, A.I., Tyurina, Y.Y., Gorelik, O., Arepalli, S., Schwegler-Berry, D., Hubbs, A.F., Antonini, J., Evans, D.E., Ku, B.K., Ramsey, D., Maynard, A., Kagan, V.E., Castranova, V., Baron, P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005;289(5):L698-L708.
91. Warheit, D.B., Laurence, B.R., Reed, K.L., Roach, D.H., Reynolds, G.A., Webb, T.R. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 2004;77(1):117-125.
92. Mitchell, L.A., Gao, J., Vander Wal, R., Gigliotti, A., Burchiel, S.W., McDonald, J.D. Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Tox Sciences 2007;100:203-214.
93. Dumortier, H., Lacotte, S., Pastorin, G., Marega, R., Wu, W., Bonifazi, D., Briand, J.P., Prato, M., Muller, S., Bianco, A. Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano Lett 2006;6(7):1522-1528.
94. Magrez, A., Kasas, S., Salicio, V., Pasquier, N., Seo, J.W., Celio, M., Catsicas, S., Schwaller, B., Forro, L. Cellular toxicity of carbon-based nanomaterials. Nano Lett 2006;6(6):1121-1125.
95. 60 water suspensions in rats: few differences in fullerenetoxicity in vivo in contrast to in vitro profiles. Nano Lett 2007;7(8):2399-23406.
96. Tian, F., Cui, D., Schwarz, H., Estrada, G.G., Kobayashi, H. Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol In Vitro 2006;20(7):1202-1212.
97. Bottini, M., Bruckner, S., Nika, K., Bottini, N., Bellucci, S., Magrini, A., Bergamaschi, A., Mustelin, T. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol Lett 2006;160(2):121-126.
98. Cui, D. Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett 2005;155:73-85.
99. Ding, L., Stilwell, J., Zhang, T., Elboudwarej, O., Jiang, H., Selegue, J.P., Cooke, P.A., Gray, J.W., Chen, F.F. Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast. Nano Lett 2005;5 (12):2448-2464.
100. Jia, G., Wang, H., Yan, L., Wang, X., Pei, R., Yan, T., Zhao, Y., Guo, X. Cytotoxicity of carbon nanomaterials: Single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol 2005;39(5):1378-1383.
101. Manna, S.K., Sarkar, S., Barr, J., Wise, K., Barrera, E.V., Jejelowo, O., Rice-Ficht, A.C., Ramesh, G.T. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytes. Nano Lett 2005;5(9): 1676-1684.
102. Monteiro-Riviere, N.A., Nemanich, R.J., Inman, A.O., Wang, Y.Y., Riviere, J.E. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 2005;155(3):377-384.
103. Sayes, C.M., Fortner, J.D., Guo, W., Lyon, D., Boyd, A.M., Ausman, K.D., Tao, Y.J., Sitharaman, B., Wilson, L.J., Hughes, J.B., West, J., Colvin, V.L. The differential cytotoxicity of water-soluble fullerenes. Nano Lett 2004;4(10):1881-1887.
104. Shvedova, A.A., Kisin, E.R., Murray, A.R., Gorelik, O., Arepalli, S., Castranova, V., Young, S.H., Gao, F., Tyurina, Y.Y., Oury, T.D., Kagan, V.E. Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by singlewalled carbon nanotubes in C57BL/6 mice. Toxicol Appl Pharmacol 2007;221(3):339-348.
105. Li, Z., Hulderman, T., Salmen, R., Chapman, R., Leonard, S.S., Young, S.H., Shvedova, S., Luster, M.I., Simeonova, P.P. Cardiovascular effects of pulmonary exposure to singlewall carbon nanotubes. Environ Health Perspect 2007;115:377-382.
106. Li, Z.J. Pulmonary exposure to carbon nanotubes induces vascular toxicity. Toxicologist 2005;84(1):213.
107. Li, Z.J. Relationship between pulmonary exposure to multiple doses of single wall carbon nanotubes and atherosclerosis in ApoE-/-mouse model. Toxicologist 2006; 90 (1):318.
108. Bell, D.C., Wu, Y., Barrelet, C.J., Gradecak, S., Xiang, J., Timko, B.P., Lieber, C.M. Imaging and analysis of nanowires. Microsc Res Tech 2004;64(5-6):373-389.
109. Patolsky, F. Nanowire nanosensors. Mater Today 2005;8(4):20-28.
110. Patolsky, F., Zheng, G., Lieber, C.M. Nanowire sensors for medicine and the life sciences. Nanomed 2006;1(1):51-65.
111. 2 nanotube arrays in dye-sensitized solar cells. Nano Lett 2006;6:215-218.
112. Huang, Y. Integrated nanoscale electronics and optoelectronics: exploring nanoscale science and technology through semiconductor nanowires. Pure Appl Chem 2004; 76 (12):2051-2068.
113. Carter, J.D., Qu, Y.R.P., Hoang, L., Masiel, D.J., Guo, T. Silicon-based nanowires from silicon wafers catalyzed by cobalt nanoparticles in hydrogen environment. Chem Commun 2005;0:2274-2276.
114. Qu, Y., Porter, R., Shan, F., Carter, J., Guo, T. Synthesis of tubular gold and silvernano-shells using silica nanowire core templates. Langmuir 2006;22:6367-6374.
115. Ekimov, A.I., Onushchenko, A.A. Quantum size effect in the optical spectra of semiconductor microcrystals. Sov Phys Semicond 1982;16:775-777.
116. Agrawal, A., Xing, Y., Gao, X., Nie S. Quantum dots. In: Vo-Dinh, T., editor. Nanotechnology in Biology and Medicine: Methods, Devices, and Applications. Boca Rotan, FL: CRC Press, Taylor & Francis Group; 2007.
117. Akerman, M.E., Chan, W.C., Laakkonen, P., Bhatia, S.N., Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 2002;99(20):12617-12621.
118. Chen, Y.F., Ji, T.H., Rosenzweig, Z. Synthesis of glyconanospheres containing luminescent CdSe-ZnS quantum dots. Nano Lett 2003;3:581-584.
119. Goldman, E.R., Balighian, E.D., Mattoussi, H., Kuno, M.K., Mauro, J.M., Tran, P.T., Anderson, G.P. Avidin: a natural bridge for quantum dot-antibody conjugates. JAm Chem Soc 2002;124:6378-6382.
120. Hanaki, K., Momo, A., Oku, T., Komoto, A., Maenosono, S., Yamaguchi, Y., Yamamoto, K. Semiconductor quantum dot/albumin complex is a long-life and highly photostable endosome marker. Biochem Biophys Res Commun 2003;302: 496-501.
121. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 2006;114(2):165-172.
122. Lingerfelt, B.M., Mattoussi, H., Goldman, E.R., Mauro, J.M., Anderson, G.P. Preparation of quantum dot-biotin conjugates and their use in immunochromatography assays. Anal Chem 2003;75:4043-4048.
123. Mahtab, R., Rogers, J.P., Murphy, C.J. Protein-sized quantum-dot luminescence can distinguish between straight, bent, and kinked oligonucleotides. J Am Chem Soc 1995;117:9099-9100.
124. Osaki, F., Kanamori, T., Sando, S., Sera, T., Aoyama, Y. A quantum dot conjugated sugar ball and its cellular uptake on the size effects of endocytosis in the subviral region. J Am Chem Soc 2004;126:6520-6521.
125. Pellegrino, T., Manna, L., Kudera, S., Liedl, T., Koktysh, D., Rogach, A.L., Keller, S., Radler, J., Natile, G., Parak, W.J. Hydrophobic nanocrystals coated with amphiphilic polymer shell: a general route to water soluble nanocrystals. Nano Lett 2004;4: 703-707.
126. Michalet, X., Pinaud, F.F., Bentolila, L.A., Tsay, J.M., Doose, S., Li, J.J., Sundaresan, G., Wu, A.M., Gambhir, S.S., Weiss, S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005;307(5709):538-544.
127. Beaurepaire, E., Buissette, V., Sauviat, M.P., Giaume, D., Lahlil, K., Mercuri, A., Casanova, D., Huignard, A., Martin, J.L., Gacoin, T., Boilot, J.-P., Alexandrou, A. Functionalized fluorescent oxide nanoparticles: artificial toxins for sodium channel targeting and imaging at the single-molecule level. Nano Lett 2004;4(11):2079-2083.
128. Colton, H.M., Falls, J.G., Ni, H., Kwanyuen, P., Creech, D., McNeil, E., Casey, W.M., Hamilton, G., Cariello, N.F. Visualization and quantitation of peroxisomes using fluorescent nanocrystals: treatment of rats and monkeys with fibrates and detection in the liver. Toxicol Sci 2004;80(1):183-192.
129. Dubertret, B., Skourides, P., Norris, D.J., Noireaux, V., Brivanlou, A.H., Libchaber, A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002;298:1759-1762.
130. Gao, X., Cui, Y., Levenson, R.M., Chung, L.W., Nie, S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004;22(8):969-976.
131. Lidke, D.S., Nagy, P., Heintzmann, R., Arndt-Jovin, D.J., Post, J.N., Grecco, H.E., Jares-Erijman, E.A., Jovin, T.M. Quantum dot ligands provide new insights into erbB/HER receptormediated signal transduction. Nat Biotechnol 2004;22(2):198-203.
132. Wu, X., Liu, H., Liu, J., Haley, K.N., Treadway, J.A., Larson, J.P., Ge, N., Peale, F., Bruchez, M.P. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2003;21(1):41-46.
133. Hopkins, L., Pinkerton, K.E. Nose-to-brain translocation of inhaled nanoparticles. Toxicologist 2007;96(1):234.
134. Ryman-Rasmussen, J.P., Riviere, J.E., Monteiro-Riviere, N.A. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 2006;91(1): 159-165.
135. Johnson, L.N., Cashman, S.M., Kumar-Singh, R. Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea. Mol Ther 2007;16:107-114.
136. Kreyling, W.G., Semmler, M., Erbe, F., Mayer, P., Takenaka, S., Schulz, H., Oberdorster, G., Ziesenis A. Translocation of ultrafine insoluble iridium particles from lungepithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 2002;65(20):1513-1530.
137. Oberdorster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., Cox, C. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004;16(6-7):437-445.
138. Derfus, A.M., Chan, W.C.W., Bhatia, S.N. Probing the cytoxicity of semiconductor quantum dots. Nano Letters 2004;4(1):11-18.
139. Tsay, J.M., Michalet, X. New light on quantum dot cytotoxicity. Chem Biol 2005; 12 (11):1159-1161.
140. Zhang, T., Stilwell, J.L., Gerion, D., Ding, L., Elboudwarej, O., Cooke, P.A., Gray, J.W., Alivisatos, A.P., Chen, F.F. Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements. Nano Lett 2006;6(4):800-808.
141. Ballou, B., Lagerholm, B.C., Ernst, L.A., Bruchez, M.P., Waggoner, A.S. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 2004;15(1):79-86.
142. Hoshino, A. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett 2004;4(11):2163-2169.
143. Brown, J.S., Zeman, K.L., Bennett, W.D. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 2002;166(9):1240-1247.
144. Kreyling, W.G., Semmler-Behnke, M., Moller, W. Ultrafine particle-lung interactions: does size matter? J Aerosol Med 2006;19(1):74-83.
145. Semmler, M., Seitz, J., Erbe, F., Mayer, P., Heyder, J., Oberdorster, G., Kreyling, W.G. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 2004; 16 (6-7):453-459.
146. Wiebert, P., Sanchez-Crespo, A., Seitz, J., Falk, R., Philipson, K., Kreyling, W.G., Moller, W., Sommerer, K., Larsson, S., Svartengren, M. Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J 2006;28(2):286-290.
147. Green, G.M. Alveolobronchiolar transport mechanisms. Arch Intern Med 1973;131 (1):109-114.
148. Takenaka, S., Karg, E., Kreyling, W.G., Lentner, B., Moller, W., Behnke-Semmler, M., Jennen, L., Walch, A., Michalke, B., Schramel, P., Heyder J., Schulz, H. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol 2006;18(10): 733-740.
149. Rinderknecht, A., Elder, A., Prud'homme, R., Gindy, M., Oberdorster, G. Are poly (ethylene glycol)-functionalized nanoparticles biocompatible? Toxicologist 2007; 96(1):232.
150. Inoue, K., Takano, H., Yanagisawa, R., Sakurai, M., Ichinose, T., Sadakane, K., Yoshi-kawa, T. Effects of nano particles on antigen-related airway inflammation in mice. Respir Res 2005;6:106-118.
151. Yamamoto, A., Honma, R., Sumita, M., Hanawa, T. Cytotoxicity evaluation of ceramic particles of different sizes and shapes. J Biomed Mater Res A 2003;68(2):244-256.
152. Elder, A., Gelein, R., Silva, V., Feikert, T., Opanashuk, L., Carter, J., Potter, R., Maynard, A., Ito, Y., Finkelstein, J., Oberdorster, G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 2006;114(8):1172-1178.
153. Elder, A., Oberdorster, G. Translocation and effects of ultrafine particles outside of the lung. Clin Occup Environ Med 2006;5(4):785-796.
154. Geldenhuys, W.J., Lockman, P.R., McAfee, J.H., Fitzpatrick, K.T., Van der Schyf, C.J., Allen, D.D. Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter. Bioorg Med Chem Lett 2004;14(12):3085-3092.
155. Henriksson, J., Tallkvist, J., Tjalve, H. Transport of manganese via the olfactory pathway in rats: dosage dependency of the uptake and subcellular distribution of the metal in the olfactory epithelium and the brain. Toxicol Appl Pharmacol 1999;156 (2):119-128.
156. Kreuter, J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001;47(1):65-81.
157. Lockman, P.R., Koziara, J.M., Mumper, R.J., Allen, D.D. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 2004a;12(9-10): 635-641.
158. Lockman, P.R., McAfee, J.H., Geldenhuys, W.J., Allen, D.D. Cation transport specificity at the blood-brain barrier. Neurochem Res 2004b;29(12):2245-2250.
159. Persson, E., Henriksson, J., Tallkvist, J., Rouleau, C., Tjalve, H. Transport and subcellular distribution of intranasally administered zinc in the olfactory system of rats and pikes. Toxicology 2003;191(2-3):97-108.
160. Nemmar, A. Passage of inhaled particles into the blood circulation in humans. Circulation 2002;105:411-414.
161. Kato, T., Yashiro, T., Murata, Y., Herbert, D.C., Oshikawa, K., Bando, M., Ohno, S., Sugiyama, Y. Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries. Cell Tissue Res 2003;311:47-51.
162. Barbeau, A. Manganese and extrapyramidal disorders. Neurotoxicology 1984;5:13-36.
163. Donaldson, J. The physiopathologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 1987;8(3):451-462.
164. Fechter, L.D., Johnson, D.L., Lynch, R.A. The relationship of particle size to olfactory nerve uptake of a non-soluble form of manganese into brain. Neurotoxicology 2002; 23(2):177-183.
165. Tjalve, H., Henriksson, J., Tallkvist, J., Larsson, B.S., Lindquist, N.G. Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacol Toxicol 1996;79(6):347-356.
166. Tjalve, H., Mejare, C., Borg-Neczak, K. Uptake and transport of manganese in primary and secondary olfactory neurones in pike. Pharmacol Toxicol 1995;77(1):23-31.
167. Hunter, D.D., Undem, B.J. Identification and Substance P content of vagal afferent neurons innervating the epithelium of the guinea pig trachea. Am J Respir Crit Care Med 1999;159(6):1943-1948.
168. Bodian, D. Experimental studies on intraneural spread of poliomyelitis virus. Bull Johns Hopkins Hosp 1941a;69:248-267.
169. Bodian, D. The rate of progression of poliomyelitis virus in nerves. Bull Johns Hopkins Hosp 1941b, 69:79-85.
170. DeLorenzo, A. The old factory neuron and the blood-brain barrier. In: Wolstenholme G., Knight J., editors. Taste and Smell in Vertebrates, London: Churchill; 1970. pp. 151-176.
171. Hunter, D.D., Dey, R.D. Identification and neuropeptide content of trigeminal neurons innervating the rat nasal epithelium. Neuroscience 1998;83(2):591-599.
172. Frampton, M.W., Stewart, J.C., Oberdorster, G., Morrow, P.E., Chalupa, D., Pietropaoli, A.P., Frasier, L.M., Speers, D.M., Cox, C., Huang, L.S., Utell, M.J. Inhalation of ultrafine particles alters blood leukocyte expression of adhesion molecules in humans. Environ Health Perspect 2006;114(1):51-58.
173. Frampton, M.W., Utell, M.J., Zareba, W., Oberdorster, G., Cox, C., Huang, L.S., Morrow, P.E., Lee, F.E., Chalupa, D., Frasier, L.M., Speer, D.M., Stewart, J. Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma. Res Rep Health Eff Inst. 2004;(126):1-47.
174. Chalupa, D.C., Morrow, P.E., Oberdorster, G., Utell, M.J., Frampton, M.W. Ultrafine particle deposition in subjects with asthma. Environ Health Perspect 2004;112(8):879-882.
175. Daigle, C.C., Chalupa, D.C., Gibb, F.R., Morrow, P.E., Oberdorster, G., Utell, M.J., Frampton, M.W. Ultrafine particle deposition in humans during rest and exercise. Inhal Toxicol 2003;15(6):539-552.
176. Mills, N.L. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med 2005;173:426-431.
177. Moller, W., Seitz, J., Sommerer, K., Heyder, J., Kreyling, W.G. Deposition and clearance of radiolabelled ultrafine carbon particles in the human airways after bolus inhalation. J Aerosol Med 2003;16(2):201.
178. Pietropaoli, A.P., Frampton, M.W., Hyde, R.W., Morrow, P.E., Oberdorster, G., Cox, C., Speers, D.M., Frasier, L.M., Chalupa, D.C., Huang, L.S., Utell, M.J. Pulmonary function, diffusing capacity, and inflammation in healthy Utell, M.J. subjects exposed to ultrafine particles. Inhal Toxicol 2004;16(Suppl 1):59-72.
179. Donaldson, K., Stone, V., Clouter, A., Renwick, L., MacNee, W. Ultrafine particles. Occup Environ Med 2001;58(3):211-216.
180. Hebert, P. Nanotech venture capital to exceed $650 million in 2006. New York: Lux Research, Inc.; 2006. http://www.luxresearchinc.com/press/RELEASE_VCreport.pdf.
181. Magrez, A., Kasas, S., Salicio, V., Pasquier, N., Seo, J.W., Celio, M., Catsicas, S., Schwaller, B., Forro, L. Cellular toxicity of carbon-based nanomaterials. Nano Lett 2006;6(6):1121-1125.
182. NNI. Funding opportunities. National Nanotechnology Initiative, Washington D.C., 2007. http://www.nano.gov/html/funding/home_funding.html.
183. Huang, Z. Longitudinal patent analysis for nanoscale science and engineering: country, institution and technology field. J Nanoparticle Res 2003;5:333-363.